Cell and Organ Transplantology. 2019; 7(1):54-59.
The effects of co-transplantation of bone marrow hematopoietic stem cell and thymic multipotent stromal cells on the immune system of mice during its regeneration after cyclophosphamide treatment
Demchenko D., Nikolskiy I.
State Institute of Genetic and Regenerative Medicine National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
The multipotent stromal cells (MSCs) are considered as one of the most promising agents for regenerating the immune system due to its powerful secretion of reparative factors and immunomodulatory properties.
The purpose of the study is to investigate the effect of co-transplantation of bone marrow hematopoietic stem cells (HSCs) and thymic multipotent stromal cells (MSCs) on regeneration of murine immune system damaged by cyclophosphamide.
Materials and methods. MSCs were obtained from thymuses of C57BL mice using explant technique. Bone marrow cells (BMCs) were obtained by flushing out the femur with nutrient medium. The immune deficiency of mice was modelled by the treatment with cyclophosphamide. After that, the cells were co-transplanted and the parameters of the immune system was evaluated. We determined the total number of erythrocytes, hematocrit, and hemoglobin concentration in peripheral blood; phases of the cell cycle and apoptosis of the cells of the mesenteric lymph nodes; the number of antibody-producing cells in the spleen; delayed type hypersensitivity (DTH); proliferative and cytotoxic activity of natural killer lymphocytes; phagocytic activity, level of spontaneous and induced bactericidal activity of peritoneal macrophages.
Results. It was shown that in contrast to BMCs, the use of MSCs alone or co-transplantation of these cells increased the spontaneous proliferative activity of lymphocytes with a significant decrease in the number of lymph node cells in G0/G1 phase by 9.2 % and an increase in the number of lymphocytes in G2-M+S phase by 35 %, as well as restoring cellularity of bone marrow, thymus and lymph nodes in mice treated with cyclophosphamide. Regeneration of erythropoiesis was stimulated by BMCs, which was manifested by the normalization of hematocrit and hemoglobin, and an increase in the number of reticulocytes in the blood by 2.2 times compared with the group of mice receiving cyclophosphamide. Co-transplantation had less pronounced, but similar effect. Transplantation of thymic MSCs stimulated the natural cytotoxicity of splenocytes by 2.7 times and substantially increased the number of antibody-producing cells in the spleen by 1.7 times compared with the group of mice receiving cyclophosphamide. Co-transplantation had a pronounced suppressive effect on the blast transformation reaction induced by phytohemagglutinin by 1.7 times, but showed a stimulating effect on DTH response by 1.46 times. Transplantation of BMCs did not affect the functional activity of the immune system.
Conclusion. The effects of co-transplantation of BMCs and thymic MSCs are realized in the several parts: stimulation of hematological parameters recovery (like under the effect of BMCs separately), normalization of cell number of lymphoid organs (as under the impact of thymic MSCs); inhibition of blast transformation activity and stimulation of DTH are the effects of co-transplantation.
Key words: bone marrow cells; thymic multipotent stromal cells; cell transplantation; regeneration of the immune system; cyclophosphamide-induced immunodeficiencyFull Text PDF (eng) Full Text PDF (ua)
|1. Grebnev DYu, Maklakova IYu, Yastrebov AP. The opportunity to use combined stem cells transplantation for haemopoesis activation in the old and mature laboratory animals under the conditions of ionizing radiation. Uspekhi Geontol. 2014; 27(2):348-352.|
|2. Nikolskaya EI, Butenko GM. Structural-functional organisation of the bone marrow hematopoietic stem cells niches. Cell and organ transplantology. 2016; 4(1):82-100.
|3. Lazarus HM, Koc ON, Devine SM, et al. Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant. 2005; 11(5):389-98.
|4. Patel DM, Shah J, Srivastava AS. Therapeutic potential of mesenchymal stem cells in regenerative medicine. Stem Cells Int. 2013; 2013. ID 496218. DOI: 10.1155/2013/496218.
|5. Xu SF, Yu LM, Fan ZH, Wu Q, Yuan Y, Wei Y, Fang N. Improvement of ginsenoside Rg1 on hematopoietic function in cyclophosphamide-induced myelosuppression mice. Eur J Pharmacol. 2012; 695(1-3):7-12. DOI: 10.1016/j.ejphar.2012.07.050.
|6. Prockop DJ, Phinney DG, Bunnell BA. Mesenchymalstem cells: methods and protocols. Totowa, NJ: Humana Press, 2008. 192 p.
|7. Gregory CA, Gunn WG, Peister A, Prockop DJ. An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem. 2004; 329(1):77-84. DOI: 10.1016/j.ab.2004.02.002.
|8. Kim WK, Jung H, Kim DH, Kim EY, Chung JW, Cho YS, et al. Regulation of adipogenic differentiation by LAR tyrosine phosphatase in human mesenchymal stem cells and 3T3-L1 preadipocytes. J Cell Sci. 2009; 122(Pt 22):4160-7. DOI: 10.1242/jcs.053009.
|9. Nikolsky IS. Dynamic features of hemo-immune deficiency induced by cyclophosphamide. Proceedings of the international forum “Clinical immunology and allergology”. 2014:195-196.|
|10. Chaitov RM, Pinihin BV, Jarilin AA. Guide to Clinical Immunology. Diagnosis of diseases of the immune system: a guide for doctors. Moskva: HEOTAR-Media, 2009. 352 p.|
|11. Frimmel G. Immunological methods edited by Frimel G. Moscow: The world, 1987. 472 p.|
|12. Mossman T. Rapid colorimetric assay for cellular growth and survival application to proliferation and cytotoxicity assay. J Immunol Methods. 1983; 65(1-2):55-63.
|13. Sugiura H, Sugiura H, Nishida H, Inaba R, Mirbod SM, Iwata H. Effects of different durations of exercise on macrophage functionsin mice. J Appl Physiol (1985). 2001; 90(3):789-94. DOI: 10.1152/jappl.2001.90.3.789.
|14. Telegin L IU. Pharmacogenetics of cyclophosphamide. Moscow: INFRA-M, 2012. 80 p.|
|15. Acar M, Kocherlakota KS, Murphy MM, Peyer JG, Oguro H, Inra CN, Jaiyeola C, Zhao Z, Luby-Phelps K, Morrison SJ. Deep imaging of bone marrow shows non-dividing stem cells are mainly perisinusoidal. Nature. 2015; 526:126-130.
|16. Abbuehl JP, Tatarova Z, Held W, Huelsken J. Long-Term Engraftment of Primary Bone Marrow Stromal Cells Repairs Niche Damage and Improves Hematopoietic Stem Cell Transplantation. Cell Stem Cell. 2017; 21(2):241-255.e6. DOI: 10.1016/j.stem.2017.07.004.
|17. Ponomaryov T, Peled A, Petit I, Taichman RS, Habler L, Sandbank J et al. Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J Clin Invest. 2000; 106(11):1331-9. DOI: 10.1172/JCI10329.
|18. Li TS, Shi H, Wang L, Yan C. Effect of Bone Marrow Mesenchymal Stem Cells on Satellite Cell Proliferation and Apoptosisin Immobilization-Induced MuscleAtrophy in Rats. Med Sci Monit. 2016; 22:4651-60.
|19. Cengiz M, Cetik Yildiz S, Demir C, Şahin İK, Teksoy Ö, Ayhanci A. Hepato-preventive and anti-apoptotic role of boric acid against liver injury induced by cyclophosphamide. J Trace Elem Med Biol. 2019; 53:1-7. DOI: 10.1016/j.jtemb.2019.01.013.
|20. Liu R, Wang Y, Zhao X, Yang Y, Zhang K. Lymphocyte inhibition is compromised in mesenchymal stem cells from psoriatic skin. Eur J Dermatol. 2014; 24(5):560-7. DOI: 10.1684/ejd.2014.2394.|
|21. Bocelli‐Tyndall C, Bracci L, Schaeren S, Feder‐Mengus C, Barbero A, Tyndall A, Spagnoli GC. Human bone marrow mesenchymal stem cells and chondrocytes promote and/or suppress the in vitro proliferation of lymphocytes stimulated by interleukins 2, 7 and 15. Ann Rheum Dis. 2009; 68(8):1352-9. DOI: 10.1136/ard.2008.094003.
|22. Saleh M, Shamsasanjan K, Movassaghpour AA, Akbarzadehlaleh P, Molaeipour Z. Inhibitory Effect of Mesenchymal Stem Cell Co-Culture on Erythroid Differentiation of K562 Cells Compared to The Control Group. Cell J. 2017; 19(1):127-136.|
|23. Maklakova IY, Grebnev DY, Yastrebov AP. Activation of regeneration of red and white pulp of the spleen after the combined transplantation of HSC and MSCS in terms of exposure to ionizing radiation. Patol Fiziol Eksp Ter. 2017; 61(2):22-7.|
Demchenko D, Nikolskiy I. The effects of co-transplantation of bone marrow hematopoietic stem cell and thymic multipotent stromal cells on the immune system of mice during its regeneration after cyclophosphamide treatment. Cell and Organ Transplantology. 2019; 7(1):54-59. doi:10.22494/cot.v7i1.95